Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713 · see citing works

Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection

Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404 · see citing works

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

Mattapallil, J. J., Douek, D. C., Hill, B. J., Nishimura, Y., Martin, M. A., & Roederer, M. (2005) · Nature · doi:10.1038/nature03501 · Cited by 1,269 · see citing works

HIV preferentially infects HIV-specific CD4+ T cells

Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P., Kuruppu, J. C., Kunstman, K., Wolinsky, S. M., et al. (2002) · Nature · doi:10.1038/417095a · Cited by 1,261 · see citing works

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173 · see citing works

Isolation of T-Cell Tropic HTLV-III-Like Retrovirus from Macaques

Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., Hunt, R. D., Kanki, P. J., Essex, M., & Desrosiers, R. C. (1985) · Science · doi:10.1126/science.3159089 · Cited by 920 · see citing works

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

McElrath, M. J., Rosa, S. C. D., Moodie, Z., Dubey, S. A., Kierstead, L. S., Janes, H., Defawe, O., Carter, D. K., Hural, J., Akondy, R. S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61592-5 · Cited by 712 · see citing works

Induction of AIDS-Like Disease in Macaque Monkeys with T-Cell Tropic Retrovirus STLV-III

Letvin, N. L., Daniel, M. D., Sehgal, P. K., Desrosiers, R. C., Hunt, R. D., Waldron, L. M., MacKey, J. J., Schmidt, D. K., Chalifoux, L. V., & King, N. W. (1985) · Science · doi:10.1126/science.2412295 · Cited by 616 · see citing works

Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1

Keele, B. F., Li, H., Learn, G. H., Hraber, P., Giorgi, E. E., Grayson, T. B., Sun, C., Chen, Y., Yeh, W. W., Letvin, N. L., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082831 · Cited by 307 · see citing works

Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus

Miller, C. J., Alexander, N. J., Sutjipto, S., Lackner, A. A., Gettie, A., Hendrickx, A. G., Lowenstine, L. J., Jennings, M. B., & Marx, P. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4277-4284.1989 · Cited by 283 · see citing works

Mamu-B * 08 -Positive Macaques Control Simian Immunodeficiency Virus Replication

Loffredo, J. T., Maxwell, J., Qi, Y., Glidden, C. E., Borchardt, G. J., Soma, T., Bean, A. T., Beal, D. R., Wilson, N. A., Rehrauer, W. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00895-07 · Cited by 283 · see citing works

Acute Loss of Intestinal CD4+ T Cells Is Not Predictive of Simian Immunodeficiency Virus Virulence

Pandrea, I., Gautam, R., Ribeiro, R. M., Brenchley, J. M., Butler, I., Pattison, M., Rasmussen, T., Marx, P. A., Silvestri, G., Lackner, A. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3035 · Cited by 280 · see citing works

Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

Casimiro, D. R., Wang, F., Schleif, W. A., Liang, X., Zhang, Z., Tobery, T. W., Davies, M.-E., McDermott, A. B., O’Connor, D. H., Fridman, A., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15547-15555.2005 · Cited by 271 · see citing works

TRIM5 Suppresses Cross-Species Transmission of a Primate Immunodeficiency Virus and Selects for Emergence of Resistant Variants in the New Species

Kirmaier, A., Wu, F., Newman, R. M., Hall, L. R., Morgan, J. S., O’Connor, S. L., Marx, P. A., Meythaler, M., Goldstein, S. C., Buckler-White, A. J., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000462 · Cited by 264 · see citing works

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B gag/pol/nef Vaccine in Healthy Adults

Priddy, F. H., Brown, D. D., Kublin, J. G., Monahan, K., Wright, D. P., Lalezari, J. P., Santiago, S., Marmor, M. F., Lally, M., Novak, R. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587993 · Cited by 249 · see citing works

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

Rolland, M., Tovanabutra, S., deCamp, A. C., Frahm, N., Gilbert, P. B., Sanders‐Buell, E., Heath, L., Magaret, C. A., Bose, M., Bradfield, A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2316 · Cited by 223 · see citing works

Expression of the Major Histocompatibility Complex Class I Molecule Mamu-A*01 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

Mothé, B. R., Weinfurter, J. T., Wang, C., Rehrauer, W. M., Wilson, N. A., Allen, T. M., Allison, D. B., & Watkins, D. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2736-2740.2003 · Cited by 206 · see citing works

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

Sprangers, M., Siegel-Lakhai, W. S., Koudstaal, W., Verhoeven, M., Koel, B. F., Vogels, R., Goudsmit, J., Havenga, M. J. E., & Kostense, S. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5046-5052.2003 · Cited by 188 · see citing works

Mutations that allow human Ad2 and Ad5 to express late genes in monkey cells map in the viral gene encoding the 72K DNA binding protein

Klessig, D. F., & Grodzicker, T. (1979) · Cell · doi:10.1016/0092-8674(79)90335-0 · Cited by 169 · see citing works

Heterologous Envelope Immunogens Contribute to AIDS Vaccine Protection in Rhesus Monkeys

Letvin, N. L., Huang, Y., Chakrabarti, B. K., Xu, L., Seaman, M. S., Beaudry, K. R., Korioth-Schmitz, B., Yu, F. H., Rohne, D., Martin, K. L., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7490-7497.2004 · Cited by 131 · see citing works

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

Buge, S. L., Richardson, E. S., Alipanah, S., Markham, P. D., Cheng, S., Kalyan, N. K., Miller, C. J., Lubeck, M. D., Udem, S. A., Eldridge, J. H., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8531-8541.1997 · Cited by 126 · see citing works

Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge

Wilson, N. A., Keele, B. F., Reed, J. S., Piaskowski, S. M., MacNair, C. E., Bett, A. J., Liang, X., Wang, F., Thoryk, E. A., Heidecker, G. J., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00272-09 · Cited by 124 · see citing works

TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys

Lim, S., Rogers, T. F., Chan, T., Whitney, J. B., Kim, J., Sodroski, J., & Letvin, N. L. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000738 · Cited by 121 · see citing works

Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys

Liu, J., Keele, B. F., Li, H. J., Keating, S. M., Norris, P. J., Carville, A., Mansfield, K. G., Tomaras, G. D., Haynes, B. F., Kolodkin‐Gal, D., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01155-10 · Cited by 112 · see citing works

The Use of Nonhuman Primate Models in HIV Vaccine Development

Morgan, C. A., Marthas, M. L., Miller, C. J., Duerr, A. C., Cheng‐Mayer, C., Desrosiers, R. C., Flores, J., Haigwood, N. L., Hu, S.-L., Johnson, R. P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050173 · Cited by 101 · see citing works

A Limited Number of Simian Immunodeficiency Virus (SIV) env Variants Are Transmitted to Rhesus Macaques Vaginally Inoculated with SIVmac251

Stone, M., Keele, B. F., Ma, Z.-M., Bailes, E., Dutra, J., Hahn, B. H., Shaw, G. M., & Miller, C. J. (2010) · Journal of Virology · doi:10.1128/jvi.00481-10 · Cited by 94 · see citing works

Patterns of CD8+Immunodominance May Influence the Ability ofMamu-B*08-Positive Macaques To Naturally Control Simian Immunodeficiency Virus SIVmac239 Replication

Loffredo, J. T., Bean, A. T., Beal, D. R., León, E. J., May, G. E., Piaskowski, S. M., Furlott, J. R., Reed, J., Musani, S. K., Rakasz, E. G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02084-07 · Cited by 88 · see citing works

An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1–infected Male Subjects: Results From a Randomized Placebo-Controlled Trial (The Step Study)

Fitzgerald, D. W., Janes, H., Robertson, M. N., Coombs, R. W., Frank, I., Gilbert, P. B., Loufty, M., Mehrotra, D. V., & Duerr, A. C. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq114 · Cited by 86 · see citing works

Animal Models for Acquired Immunodeficiency Syndrome

Desrosiers, R. C., & Letvin, N. L. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.3.438 · Cited by 79 · see citing works

Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys

Liang, X., Casimiro, D. R., Schleif, W. A., Wang, F., Davies, M.-E., Zhang, Z., Fu, T., Finnefrock, A. C., Handt, L., Citron, M. P., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12321-12331.2005 · Cited by 77 · see citing works

Preferential Infection Shortens the Life Span of Human ImmunodeficiencyVirus-Specific CD4+T Cells In Vivo

Brenchley, J. M., Ruff, L. E., Casazza, J. P., Koup, R. A., Price, D. A., & Douek, D. C. (2006) · Journal of Virology · doi:10.1128/jvi.00070-06 · Cited by 75 · see citing works

Potent, Persistent Induction and Modulation of Cellular Immune Responses in Rhesus Macaques Primed with Ad5hr-Simian Immunodeficiency Virus (SIV) env/rev , gag , and/or nef Vaccines and Boosted with SIV gp120

Patterson, L. J., Malkevitch, N., Pinczewski, J., Venzon, D. J., Lou, Y., Peng, B., Munch, C., Leonard, M., Richardson, E. S., Aldrich, K., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8607-8620.2003 · Cited by 62 · see citing works

With Minimal Systemic T-Cell Expansion, CD8+T Cells Mediate Protection of Rhesus Macaques Immunized with Attenuated Simian-Human Immunodeficiency Virus SHIV89.6 from Vaginal Challenge with Simian Immunodeficiency Virus

Genescà, M., Skinner, P. J., Hong, J. J., Li, J., Ding, L., McChesney, M. B., & Miller, C. J. (2008) · Journal of Virology · doi:10.1128/jvi.01433-08 · Cited by 58 · see citing works

Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6

Genescà, M., McChesney, M. B., & Miller, C. J. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02051.x · Cited by 56 · see citing works

Assessing Vaccine Effects in Repeated Low‐Dose Challenge Experiments

Hudgens, M. G., & Gilbert, P. B. (2009) · Biometrics · doi:10.1111/j.1541-0420.2009.01189.x · Cited by 55 · see citing works

Real-Time PCR with an Internal Control for Detection of All Known Human Adenovirus Serotypes

Damen, M., Minnaar, R., Glasius, P., van der Ham, A. J., Koen, G., Dillen, P. M. E. W., & Beld, M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00563-08 · Cited by 54 · see citing works

Cytotoxic T-Lymphocyte Escape Does Not Always Explain the Transient Control of Simian Immunodeficiency Virus SIVmac239 Viremia in Adenovirus-Boosted and DNA-Primed Mamu-A*01-Positive Rhesus Macaques

McDermott, A. B., O’Connor, D. H., Fuenger, S., Piaskowski, S. M., Martin, S., Loffredo, J. T., Reynolds, M. R., Reed, J. S., Furlott, J. R., Jacoby, T. J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15556-15566.2005 · Cited by 52 · see citing works

SIVmac251 Is Inefficiently Transmitted to Rhesus Macaques by Penile Inoculation with a Single SIV env Variant Found in Ramp-up Phase Plasma

Ma, Z.-M., Keele, B. F., Qureshi, H., Stone, M., DeSilva, V., Fritts, L., Lifson, J. D., & Miller, C. J. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0090 · Cited by 49 · see citing works

Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans

Pine, S. O., Kublin, J. G., Hammer, S. M., Borgerding, J. A., Huang, Y., Casimiro, D. R., & McElrath, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018526 · Cited by 48 · see citing works

The TRIM5 Gene Modulates Penile Mucosal Acquisition of Simian Immunodeficiency Virus in Rhesus Monkeys

Yeh, W. W., Rao, S. S., Lim, S., Zhang, J., Hraber, P., Brassard, L. M., Luedemann, C., Todd, J. P., Dodson, A., Shen, L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00854-11 · Cited by 47 · see citing works

Power to Detect the Effects of HIV Vaccination in Repeated Low‐Dose Challenge Experiments

Hudgens, M. G., Gilbert, P. B., Mascola, J. R., Wu, C., Barouch, D. H., & Self, S. G. (2009) · The Journal of Infectious Diseases · doi:10.1086/600891 · Cited by 45 · see citing works

Mucosal Transmission of Simian Immunodeficiency Virus

Miller, C. J. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78536-8_6 · Cited by 43 · see citing works

Host Genetic Determinants of T Cell Responses to the MRKAd5 HIV-1 gag/pol/nef Vaccine in the Step Trial

Fellay, J., Frahm, N., Shianna, K. V., Cirulli, E. T., Casimiro, D. R., Robertson, M. N., Haynes, B. F., Geraghty, D. E., McElrath, M. J., & Goldstein, D. B. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq125 · Cited by 43 · see citing works

Efficacy of Multivalent Adenovirus-Based Vaccine against Simian Immunodeficiency Virus Challenge

Casimiro, D. R., Cox, K., Tang, A., Sykes, K. J., Feng, M., Wang, F., Bett, A. J., Schleif, W. A., Liang, X., Flynn, J. A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00969-09 · Cited by 35 · see citing works

Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case–control study

Curlin, M. E., Cassis-Ghavami, F. L., Magaret, A., Spies, G. A., Duerr, A. C., Celum, C., Sánchez, J., Margolick, J. B., Detels, R., McElrath, M. J., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328342115c · Cited by 31 · see citing works

Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus

Stone, M., Ma, Z.-M., Genescà, M., Fritts, L., Blozois, S., McChesney, M. B., & Miller, C. J. (2009) · Virology · doi:10.1016/j.virol.2009.06.052 · Cited by 26 · see citing works

Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection

Kim, J. H., Excler, J., & Michael, N. L. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-052912-123749 · Cited by 174 · see citing works

Merck Ad5/HIV induces broad innate immune activation that predicts CD8 + T-cell responses but is attenuated by preexisting Ad5 immunity

Zak, D. E., Andersen‐Nissen, E., Peterson, E. R., Sato, A., Hamilton, M. K., Borgerding, J. A., Krishnamurty, A. T., Chang, J. T., Adams, D. J., Hensley, T. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208972109 · Cited by 162 · see citing works

Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers

Pauthner, M. G., Nkolola, J. P., Havenar‐Daughton, C., Murrell, B., Reiss, S. M., Bastidas, R. B., Prévost, J., Nedellec, R., von Bredow, B., Abbink, P., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.11.011 · Cited by 156 · see citing works

Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIV mac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial

Pegu, P., Vaccari, M., Gordon, S. N., Keele, B. F., Doster, M. N., Guan, Y., Ferrari, G., Pal, R., Ferrari, M. G., Whitney, S., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02544-12 · Cited by 132 · see citing works

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

Gray, G., Moodie, Z., Metch, B. J., Gilbert, P. B., Bekker, L., Churchyard, G., Nchabeleng, M., Mlisana, K. P., Laher, F., Roux, S., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70020-9 · Cited by 121 · see citing works

Harnessing CD4+ T cell responses in HIV vaccine development

Streeck, H., D’Souza, M. P., Littman, D. R., & Crotty, S. (2013) · Nature Medicine · doi:10.1038/nm.3054 · Cited by 96 · see citing works

Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development

Lewis, G. K., DeVico, A. L., & Gallo, R. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413550111 · Cited by 87 · see citing works

Activated CD4 + CCR5 + T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques

Carnathan, D. G., Wetzel, K. S., Yu, J., Lee, S. T., Johnson, B. A., Paiardini, M., Yan, J., Morrow, M. P., Sardesai, N. Y., Weiner, D. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407466112 · Cited by 87 · see citing works

Vaccine Strategies to Elicit Mucosal Immunity

Song, Y., Mehl, F., & Zeichner, S. L. (2024) · Vaccines · doi:10.3390/vaccines12020191 · Cited by 80 · see citing works

Immune Activation with HIV Vaccines

Fauci, A. S., Marovich, M., Dieffenbach, C. W., Hunter, E., & Buchbinder, S. (2014) · Science · doi:10.1126/science.1250672 · Cited by 78 · see citing works

Newer Gene Editing Technologies toward HIV Gene Therapy

Manjunath, N., Yi, G., Dang, Y., & Shankar, P. (2013) · Viruses · doi:10.3390/v5112748 · Cited by 77 · see citing works

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition

Vaccari, M., Fourati, S., Gordon, S. N., Brown, D. R., Bissa, M., Schifanella, L., de Castro, I. S., Doster, M. N., Galli, V., Omsland, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0025-7 · Cited by 73 · see citing works

Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates

Richardson, J. S., Pillet, S., Bello, A., & Kobinger, G. P. (2013) · Journal of Virology · doi:10.1128/jvi.02864-12 · Cited by 71 · see citing works

Challenges in HIV Vaccine Research for Treatment and Prevention

Ensoli, B., Cafaro, A., Monini, P., Marcotullio, S., & Ensoli, F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00417 · Cited by 65 · see citing works

Use of adenovirus type-5 vectored vaccines: a cautionary tale

Buchbinder, S., McElrath, M. J., Dieffenbach, C. W., & Corey, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32156-5 · Cited by 62 · see citing works

Nonhuman Primate Models for HIV/AIDS Vaccine Development

Sui, Y., Gordon, S. N., Franchini, G., & Berzofsky, J. A. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1214s102 · Cited by 57 · see citing works

Molecularly Tagged Simian Immunodeficiency Virus SIVmac239 Synthetic Swarm for Tracking Independent Infection Events

Prete, G. Q. D., Park, H., Fennessey, C. M., Reid, C., Lipkey, L., Newman, L. P., Oswald, K. A., Kahl, C., Piatak, M., Quiñones, O. A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01026-14 · Cited by 53 · see citing works

HIV vaccinology: 2021 update

Lee, J. H., & Crotty, S. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101470 · Cited by 52 · see citing works

Mucosal Priming with a Replicating-Vaccinia Virus-Based Vaccine Elicits Protective Immunity to Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

Sun, C., Chen, Z., Tang, X., Zhang, Y., Feng, L., Du, Y., Xiao, L., Liu, L., Zhu, W., Chen, L., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03247-12 · Cited by 49 · see citing works

Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

Hu, H., Eller, M. A., Zafar, S. J., Zhou, Y., Gu, M., Wei, Z., Currier, J. R., Marovich, M., Kibuuka, H. N., Bailer, R. T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400446111 · Cited by 49 · see citing works

Targeting the Genital Tract Mucosa with a Lipopeptide/Recombinant Adenovirus Prime/Boost Vaccine Induces Potent and Long-Lasting CD8+ T Cell Immunity against Herpes: Importance of MyD88

Zhang, X., Dervillez, X., Chentoufi, A. A., Badakhshan, T., Bettahi, I., & BenMohamed, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201121 · Cited by 47 · see citing works

Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Vectors Efficiently Prime SIV-Specific Systemic and Mucosal Immune Responses by Targeting Myeloid Dendritic Cells and Persisting in Rectal Macrophages, Regardless of Immunization Route

Patterson, L. J., Kuate, S., Daltabuit-Test, M., Li, Q., Xiao, P., McKinnon, K. M., DiPasquale, J., Cristillo, A. D., Venzon, D. J., Haase, A. T., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00010-12 · Cited by 46 · see citing works

Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines

Yang, Y., & Iwasaki, A. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00590-x · Cited by 42 · see citing works

Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies

Prete, G. Q. D., Lifson, J. D., & Keele, B. F. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000311 · Cited by 42 · see citing works

The contribution of non-human primate models to the development of human vaccines.

Rivera-Hernández, T., Carnathan, D. G., Moyle, P. M., Tóth, I., West, N. P., Young, P. R., Silvestri, G., & Walker, M. J. (2014) · PubMed · Cited by 42 · see citing works

Prospects for a Globally Effective HIV-1 Vaccine

Excler, J., Robb, M. L., & Kim, J. H. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.09.004 · Cited by 41 · see citing works

A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge

Reynolds, M. R., Weiler, A. M., Piaskowski, S. M., Piatak, M., Robertson, H. T., Allison, D. B., Bett, A. J., Casimiro, D. R., Shiver, J. W., Wilson, N. A., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.082 · Cited by 39 · see citing works

HIV-1 vaccines

Excler, J., Robb, M. L., & Kim, J. H. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28462 · Cited by 38 · see citing works

Risk of Immunodeficiency Virus Infection May Increase with Vaccine-Induced Immune Response

Tenbusch, M., Ignatius, R., Temchura, V., Nabi, G., Tippler, B. G., Stewart-Jones, G., Salazar, A. Μ., Sauermann, U., Stahl‐Hennig, C., & Überla, K. (2012) · Journal of Virology · doi:10.1128/jvi.00796-12 · Cited by 38 · see citing works

Tackling HIV and AIDS: contributions by non-human primate models

Rompay, K. K. A. V. (2017) · Lab Animal · doi:10.1038/laban.1279 · Cited by 38 · see citing works

Lessons Learned from HIV Vaccine Clinical Efficacy Trials

Day, T., & Kublin, J. G. (2014) · Current HIV Research · doi:10.2174/1570162x113116660051 · Cited by 37 · see citing works

Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART

Peterson, C. W., Younan, P. M., Jerome, K. R., & Kiem, H.-P. (2013) · Gene Therapy · doi:10.1038/gt.2012.98 · Cited by 36 · see citing works

Antibody to the gp120 V1/V2 Loops and CD4+ and CD8+ T Cell Responses in Protection from SIVmac251 Vaginal Acquisition and Persistent Viremia

Gordon, S. N., Doster, M. N., Kines, R. C., Keele, B. F., Brocca‐Cofano, E., Guan, Y., Pegu, P., Liyanage, N. P. M., Vaccari, M., Çuburu, N., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401504 · Cited by 35 · see citing works

Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition

Gordon, S. N., Liyanage, N. P. M., Doster, M. N., Vaccari, M., Vargas‐Inchaustegui, D. A., Pegu, P., Schifanella, L., Shen, X., Tomaras, G. D., Rao, M., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600674 · Cited by 34 · see citing works

Prospects for a globally effective HIV-1 vaccine

Excler, J., Robb, M. L., & Kim, J. H. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.059 · Cited by 33 · see citing works

Using nonhuman primates to model HIV transmission

Fennessey, C. M., & Keele, B. F. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328361cfff · Cited by 30 · see citing works

The influence of delivery vectors on HIV vaccine efficacy

Ondondo, B. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00439 · Cited by 29 · see citing works

HIV transmission biology

Ronen, K., Sharma, A., & Overbaugh, J. M. (2015) · AIDS · doi:10.1097/qad.0000000000000845 · Cited by 29 · see citing works

The translational value of non-human primates in preclinical research on infection and immunopathology

Hart, B. A. ‘., Bogers, W. M. J. M., Haanstra, K. G., Verreck, F. A. W., & Kocken, C. H. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.023 · Cited by 29 · see citing works

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

Huang, Y., Follmann, D. A., Nason, M., Zhang, L., Huang, Y., Mehrotra, D. V., Moodie, Z., Metch, B. J., Janes, H., Keefer, M. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136626 · Cited by 27 · see citing works

Animal models in virus research: their utility and limitations

Louz, D., Bergmans, H. E. N., Loos, B. P., & Hoeben, R. C. (2012) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.711740 · Cited by 24 · see citing works

Lymphatic Dissemination of Simian Immunodeficiency Virus after Penile Inoculation

Ma, Z.-M., Dutra, J., Fritts, L., & Miller, C. J. (2016) · Journal of Virology · doi:10.1128/jvi.02947-15 · Cited by 23 · see citing works

Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects

Kaur, A., & Vaccari, M. (2024) · Viruses · doi:10.3390/v16030368 · Cited by 22 · see citing works

Lessons from HIV-1 vaccine efficacy trials

Excler, J., & Michael, N. L. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000312 · Cited by 22 · see citing works

Clinical trials and recent progress in HIV vaccine development

Zubair, A., Bibi, B., Habib, F., Sujan, A., & Ali, M. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01425-9 · Cited by 21 · see citing works

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study

Huang, Y., Duerr, A. C., Frahm, N., Zhang, L., Moodie, Z., Rosa, S. D., McElrath, M. J., & Gilbert, P. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108631 · Cited by 21 · see citing works

What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans?Preprint

Martins, M. A., & Watkins, D. I. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029504 · Cited by 21 · see citing works

Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.

Chentoufi, A. A., Dervillez, X., Rubbo, P., Kuo, T., Zhang, X., Nagot, N., Tuaillon, É., de Perre, P. V., Nesburn, A. B., & BenMohamed, L. (2012) · PubMed · Cited by 20 · see citing works

Current advances in HIV vaccine preclinical studies using Macaque models

Liang, B., Li, H., Li, L., Omange, R. W., Hai, Y., & Luo, M. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.094 · Cited by 20 · see citing works

Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate

Vaccari, M., Fourati, S., Brown, D. R., de Castro, I. S., Bissa, M., Schifanella, L., Doster, M. N., Foulds, K. E., Roederer, M., Koup, R. A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01072 · Cited by 19 · see citing works

Strong T H 1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy

Chamcha, V., Reddy, P. B. J., Kannanganat, S., Wilkins, C. R., Gangadhara, S., Velu, V., Green, R. R., Law, G. L., Chang, J., Bowen, J. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav1800 · Cited by 19 · see citing works

Viral RNA Levels and env Variants in Semen and Tissues of Mature Male Rhesus Macaques Infected with SIV by Penile Inoculation

Fiéni, F., Stone, M., Ma, Z.-M., Dutra, J., Fritts, L., & Miller, C. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076367 · Cited by 18 · see citing works

Accelerating HIV vaccine development using non-human primate models

Rahman, M. A., & Robert-Guroff, M. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1557521 · Cited by 17 · see citing works

Ebola virus vaccine: benefit and risks of adenovirus-based vectors

Mennechet, F. J. D., Tran, T. T. P., Eichholz, K., de Perre, P. V., & Kremer, E. J. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1083429 · Cited by 16 · see citing works

Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope

Matchett, W. E., Malewana, G. B. R., Mudrick, H. E., Medlyn, M. J., & Barry, M. A. (2020) · Vaccines · doi:10.3390/vaccines8010064 · Cited by 16 · see citing works

Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4 + and CD8 + T-Cell Responses

Sauermann, U., Radaelli, A., Stolte, N., Raue, K., Bissa, M., Zanotto, C., Krawczak, M., Tenbusch, M., Überla, K., Keele, B. F., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01120-17 · Cited by 15 · see citing works

Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines

Klasse, P. J., & Moore, J. P. (2012) · Retrovirology · doi:10.1186/1742-4690-9-80 · Cited by 15 · see citing works

New directions for HIV vaccine development from animal models

McChesney, M. B., & Miller, C. J. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328363d3a2 · Cited by 14 · see citing works

Dispelling myths and focusing on notable concepts in HIV pathogenesis

Levy, J. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.004 · Cited by 14 · see citing works

Infection with Host-Range Mutant Adenovirus 5 Suppresses Innate Immunity and Induces Systemic CD4+ T Cell Activation in Rhesus Macaques

Qureshi, H., Genescà, M., Fritts, L., McChesney, M. B., Robert-Guroff, M., & Miller, C. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106004 · Cited by 14 · see citing works

Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?

Dezzutti, C. S. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.1.20301 · Cited by 13 · see citing works

Monkey Models and HIV Vaccine Research

Chen, Z. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0484-2_5 · Cited by 12 · see citing works

Macaque models of enhanced susceptibility to HIV

Henning, T., McNicholl, J. M., Vishwanathan, S. A., & Kersh, E. N. (2015) · Virology Journal · doi:10.1186/s12985-015-0320-6 · Cited by 11 · see citing works

Adenovirus vectors as HIV-1 vaccines

D’Souza, M. P., & Yang, O. O. (2014) · AIDS · doi:10.1097/qad.0000000000000548 · Cited by 11 · see citing works

Augmented Replicative Capacity of the Boosting Antigen Improves the Protective Efficacy of Heterologous Prime-Boost Vaccine Regimens

Penaloza‐MacMaster, P., Teigler, J. E., Obeng, R. C., Kang, Z. H., Provine, N. M., Parenteau, L. R., Blackmore, S., Ra, J., Borducchi, E. N., & Barouch, D. H. (2014) · Journal of Virology · doi:10.1128/jvi.00406-14 · Cited by 11 · see citing works

Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques

Demberg, T., Brocca‐Cofano, E., Kuate, S., Aladi, S., Vargas‐Inchaustegui, D. A., Venzon, D. J., Kalisz, I., Kalyanaraman, V. S., Lee, E. M., Pal, R., et al. (2013) · Virology · doi:10.1016/j.virol.2013.02.024 · Cited by 10 · see citing works

Clustered epitopes within a new poly-epitopic HIV-1 DNA vaccine shows immunogenicity in BALB/c mice

Jafarpour, N., Memarnejadian, A., Aghasadeghi, M. R., Kohram, F., Aghababa, H., Khoramabadi, N., & Mahdavi, M. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3388-y · Cited by 10 · see citing works

Antiviral Antibodies and T Cells Are Present in the Foreskin of Simian Immunodeficiency Virus-Infected Rhesus Macaques

Rothaeusler, K., Ma, Z.-M., Qureshi, H., Carroll, T. D., Rourke, T., McChesney, M. B., & Miller, C. J. (2012) · Journal of Virology · doi:10.1128/jvi.00410-12 · Cited by 9 · see citing works

Phenotypic and Functional Signatures of Herpes Simplex Virus–Specific Effector Memory CD73+CD45RAhighCCR7lowCD8+ TEMRA and CD73+CD45RAlowCCR7lowCD8+ TEM Cells Are Associated with Asymptomatic Ocular Herpes

Srivastava, R., Coulon, P.-G. A., Roy, S., Chilukuri, S., Garg, S., & BenMohamed, L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800725 · Cited by 9 · see citing works

Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV

Garber, D. A., Mitchell, J. M., Adams, D., Guenthner, P. C., Deyounks, F., Ellis, S., Kelley, K., Johnson, R., Dobard, C., Heneine, W., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194837 · Cited by 8 · see citing works

HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response

Hu, H., Liu, F., Kim, J. H., & Ratto‐Kim, S. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1147354 · Cited by 8 · see citing works

Ebola vaccines based on adenovirus vectors and risk of HIV

Kremer, E. J., & de Perre, P. V. (2015) · BMJ · doi:10.1136/bmj.h1307 · Cited by 8 · see citing works

The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!

Temchura, V., & Tenbusch, M. (2014) · Virologica Sinica · doi:10.1007/s12250-014-3419-9 · Cited by 7 · see citing works

Adenovirus Serotype 26 and 35 Vectors Induce Simian Immunodeficiency Virus-Specific T Lymphocyte Responses in Foreskin in Rhesus Monkeys

Balandya, E., Miller, A. D., Beck, M., Liu, J., Li, H., Borducchi, E. N., Smith, K. M., Cabral, C., Stanley, K. A., Maxfield, L. F., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03771-13 · Cited by 7 · see citing works

Simian-Human Immunodeficiency Viruses and Their Impact on Non-Human Primate Models for AIDS

Lara, E., Srinivasan, P., & James, M. R. (2012) · InTech eBooks · doi:10.5772/53556 · Cited by 5 · see citing works

A discrete-time survival model with random effects for designing and analyzing repeated low-dose challenge experiments

Kang, C., Huang, Y., & Miller, C. J. (2014) · Biostatistics · doi:10.1093/biostatistics/kxu040 · Cited by 5 · see citing works

New prospects for a preventive HIV-1 vaccine.

Brown, J., Excler, J., & Kim, J. H. (2015) · PubMed Central · Cited by 4 · see citing works

Rise of Macaque Models for Immunity and Infection Research

Acharya, A., & Byrareddy, S. N. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_6 · Cited by 3 · see citing works

DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells

Reuter, M. A., Yuan, S., Marx, P. A., Kutzler, M. A., Weiner, D. B., & Betts, M. R. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22247 · Cited by 3 · see citing works

Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques

Dorta-Estremera, S. M., Nehete, P. N., Yang, G., He, H., Nehete, B. P., Shelton, K., Barry, M. A., & Sastry, K. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188807 · Cited by 3 · see citing works

Mucosal Immunity and Vaccines Against Simian Immunodeficiency Virus and Human Immunodeficiency Virus

McElrath, M. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00060-4 · Cited by 2 · see citing works

A method to address between‐subject heterogeneity for identification of principal surrogate markers in repeated low‐dose challenge HIV vaccine studies

Spieker, A. J., & Huang, Y. (2017) · Statistics in Medicine · doi:10.1002/sim.7419 · Cited by 2 · see citing works

Forty years on: how close is an HIV vaccine?

Greener, M. (2021) · Prescriber · doi:10.1002/psb.1919 · Cited by 2 · see citing works

Humanized Mouse Versus Non-human Primate Models of HIV-1 Infection

Li, Q., & Wood, C. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1655-9_17 · Cited by 1 · see citing works

Efficacy Trials and Progress of HIV Vaccines

Asif, D. F., & Irshad, M. (2017) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000265

Qualitative Characteristics of HIV-1-Specific CD4+ T Cells Responses Associated With Broadly Neutralizing Antibody Response

Kadariswantiningsih, I. N. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Construction of a Simian Immunodeficiency Virus Vaccine from Cynomolgus Macaque Cytomegalovirus

Russell, J. N. H. (2018) · TSpace (University of Toronto)

Mucosal immune stimulation with HSV-2 and polyICLC boosts control of viremia in SIVΔNef vaccinated rhesus macaques with breakthrough SIV infectionPreprint

Aravantinou, M., Mizenina, O. A., Brill, T., Kenney, J., Timmons, C. L., Frank, I., Gettie, A., Grasperge, B. F., Blanchard, J., Salazar, A. Μ., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.02.129494

Immunobiological Correlates of SIV Vaccine Vectors and Macaque Tropism

Antony, J. M. (2019) · Vaccine Research · doi:10.29252/vacres.6.2.23

Immunogenicity of HIV-1 Env-Gag VLP mRNA and Adenovirus Vector Vaccines in Mice

Yang, J., Ma, Q., He, X., Li, H., Zhang, X., Hao, Y., & Feng, X. (2025) · Vaccines · doi:10.3390/vaccines13121242

Consequences of Adenovirus Vector Vaccination on T Cell Activation and SIV Susceptibility in Rhesus Macaques

Brody, I. B. (2014) · Scholarly Commons (University of Pennsylvania)

A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge

Reynolds, M. R., Weiler, A. M., Piaskowski, S. M., Piatak, M., Robertson, H. T., Allison, D. B., Bett, A. J., Casimiro, D. R., Shiver, J. W., Wilson, N. A., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.082 · Cited by 39 · see citing works

Susceptibility to SIV Infection After Adenoviral Vaccination in a Low Dose Rhesus Macaque Challenge Model

Brody, I. B., Calcedo, R., Connell, M. J., Carnathan, D. G., Nason, M., Lawson, B., Nega, M. T., Boyd, S., Qin, Q., Vanderford, T. H., et al. (2019) · Pathogens and Immunity · doi:10.20411/pai.v4i1.241 · Cited by 3 · see citing works

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

Buge, S. L., Richardson, E. S., Alipanah, S., Markham, P. D., Cheng, S., Kalyan, N. K., Miller, C. J., Lubeck, M. D., Udem, S. A., Eldridge, J. H., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8531-8541.1997 · Cited by 126 · see citing works

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

Gray, G., Buchbinder, S., & Duerr, A. C. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833d2d2b · Cited by 172 · see citing works